SANOFI-AVENTIS V SANDOZ INC, No. 09-1427 (Fed. Cir. 2009)
Annotate this Case
Download PDF
NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit 2009-1427 SANOFI-AVENTIS U.S. LLC, SANOFI-AVENTIS, and DEBIOPHARM S.A., Plaintiffs-Appellants, v. SANDOZ, INC., Defendant-Appellee, and TEVA PARENTERAL MEDICINES, INC., TEVA PHARMACEUTICALS USA, INC., and PHARMACHEMIE BV, Defendants-Appellees, and MAYNE PHARMA LIMITED, MAYNE PHARMA (USA) INC., HOSPIRA AUSTRALIA PTY LTD., and HOSPIRA, INC., Defendants-Appellees, and BARR LABORATORIES, INC. and PLIVA-LACHEMA A.S., Defendants-Appellees, and W.C. HERAEUS GMBH, Defendant-Appellee, and APP PHARMACEUTICALS, INC. and ABRAXIS BIOSCIENCE, INC., Defendants-Appellees, and ACTAVIS TOTOWA LLC, ACTAVIS, INC., and ACTAVIS GROUP HF, Defendants-Appellees, and FRESENIUS KABI ONCOLOGY PLC (formerly known as Dabur Oncology plc) and FRESENIUS KABI PHARMA LIMITED (formerly known as Dabur Pharma Limited), Defendants-Appellees, and SUN PHARMACEUTICAL INDUSTRIES LTD. and CARACO PHARMACEUTICAL LABORATORIES, LTD., Defendants-Appellees, and EBEWE PHARMA GES.M.B.H. NFG KG, Defendants, and MUSTAFA NEVZAT ILAC SANAYII A.S. (also known as MN Pharmaceuticals), PAR PHARMACEUTICAL COMPANIES, INC., and PAR PHARMACEUTICAL, INC., Defendants-Appellees. On appeal from the United States District Court for the District of New Jersey in case no. 3:07-cv-2762, Judge Joel A. Pisano. ON MOTION Before MAYER, CLEVENGER, and RADER, Circuit Judges. MAYER, Circuit Judge. ORDER 2009-1427 -2- Mayne Pharma Limited et al. (Mayne) and Teva Parenteral et al. (Teva) move for clarification of the court's July 10, 2009 order granting Sanofi-Aventis U.S. LLC et al.'s (Sanofi) motion for a stay, pending appeal, of the judgment of the United States District Court for the District of New Jersey entered on June 30, 2009 and also move for a conditional limited remand to the district court for the purpose of fixing the amount of a supersedeas bond. Sandoz, Inc. responds. Mayne and Teva move for a 14-day extension of time, until August 7, 2009, to file a petition for panel rehearing and/or rehearing en banc of the court's July 10 order. Ebewe Pharma Ges.m.b.H. Nfg.KG moves for leave to be removed from this appeal due to a consent judgment entered by the district court resolving the litigation between Ebewe and Sanofi. Upon consideration thereof, IT IS ORDERED THAT: The motion for clarification is denied. The motion for a limited remand is deemed moot. The motion for an extension of time to file a rehearing petition is granted. The motion to remove Ebewe from this appeal is granted to the extent that Ebewe is no longer designated as an appellee in the court's caption. The revised official caption is reflected above. FOR THE COURT JUL 24 2009 /s/ Jan Horbalv Jan Horbaly Clerk Date Pits, U.S. wow oF APPEALS PM THE FEDERAL CIRCUIT JUL 2 4 2009 2009-1427 -3- JAN NONtimur CLERK cc: s19 Dominick A. Conde, Esq. Frederick H. Rein, Esq. Gail J. Standish, Esq. Patricia J. Thompson, Esq. Scott B. Feder, Esq. Steven Lieberman, Esq. Steven A. Maddox, Esq. Charles D. Ossola, Esq. Andrew M. Berdon, Esq. Daniel G. Brown, Esq. Steven H. Sklar, Esq.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
